BamSEC and AlphaSense Join Forces
Learn More

Prelude Therapeutics Incorporated – Articles of Incorporation

NASDAQ: PRLD    
Share price (8/24/26): $6.47    
Market cap (8/24/26): $516 million

Articles of Incorporation Filter

EX-3.1
from 10-Q 9 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Prelude Therapeutics Incorporated
12/34/56
EX-3.1
from 10-Q 8 pages Prelude Therapeutics Incorporated Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 31 pages Prelude Therapeutics Incorporated (A Delaware Corporation) Amended and Restated Bylaws as Amended and Restated on January 19, 2023 Prelude Therapeutics Incorporated (A Delaware Corporation) Amended and Restated Bylaws
12/34/56
EX-3.2
from 10-Q 27 pages Prelude Therapeutics Incorporated (A Delaware Corporation) Restated Bylaws as Adopted September 14, 2020 and as Effective September 29, 2020 Prelude Therapeutics Incorporated (A Delaware Corporation) Restated Bylaws
12/34/56
EX-3.1
from 10-Q 7 pages Prelude Therapeutics Incorporated Restated Certificate of Incorporation
12/34/56
EX-3.1
from S-1/A 30 pages Fifth Amended and Restated Certificate of Incorporation of Prelude Therapeutics Incorporated
12/34/56
EX-3.4
from S-1/A 27 pages Prelude Therapeutics Incorporated (A Delaware Corporation) Restated Bylaws as Adopted [•], 2020 and as Effective [•], 2020 Prelude Therapeutics Incorporated (A Delaware Corporation) Restated Bylaws
12/34/56
EX-3.2
from S-1/A 7 pages Prelude Therapeutics Incorporated Restated Certificate of Incorporation
12/34/56
EX-3.3
from S-1 20 pages Prelude Therapeutics Incorporated Amended and Restated Bylaws
12/34/56
EX-3.1
from S-1 28 pages Fifth Amended and Restated Certificate of Incorporation of Prelude Therapeutics Incorporated
12/34/56
EX-3.3
from DRS/A 20 pages Prelude Therapeutics Incorporated Amended and Restated Bylaws
12/34/56
EX-3.1
from DRS/A 28 pages Fifth Amended and Restated Certificate of Incorporation of Prelude Therapeutics Incorporated
12/34/56